Terns Pharmaceuticals, Inc. (FRA:430)
31.20
-0.60 (-1.89%)
At close: Jan 16, 2026
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of €3.17 billion as of January 30, 2026. Its market cap has increased by 728.75% in one year.
Market Cap
3.17B
Enterprise Value
2.92B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€31.20
Market Cap Chart
Since February 5, 2021, Terns Pharmaceuticals's market cap has increased from 119.38M to 3.17B, an increase of 2,553.31%. That is a compound annual growth rate of 92.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 3.17B | -15.36% |
| Dec 31, 2025 | 3.74B | 723.41% |
| Dec 31, 2024 | 454.52M | 25.27% |
| Dec 29, 2023 | 362.83M | -23.08% |
| Dec 30, 2022 | 471.66M | 200.27% |
| Dec 31, 2021 | 157.08M | 31.57% |
| Feb 5, 2021 | 119.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.45B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.80B |
| tonies SE | 1.14B |
| Sedlmayr Grund und Immobilien AG | 939.90M |
| Berliner Effektengesellschaft AG | 879.96M |
| Maschinenfabrik Berthold Hermle AG | 835.00M |